Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma

Author:

Munshi Pashna N.,Chen Yue,Ahn Kwang W.ORCID,Awan Farrukh T.ORCID,Cashen Amanda,Shouse GeoffreyORCID,Shadman Mazyar,Shaughnessy Paul,Zurko Joanna,Locke Frederick L.,Goodman Aaron M.,Bisneto Jose C. Villaboas,Sauter Craig,Kharfan-Dabaja Mohamad A.ORCID,Meyers GabrielleORCID,Jaglowski Samantha,Herrera Alex,Hamadani MehdiORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference45 articles.

1. Cancer Facts & Figures 2022,2022

2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

3. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database;Ban-Hoefen;Br J Haematol,2013

4. Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy;Kanate;Biol Blood Marrow Transplant,2020

5. High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party;Sweetenham;Bone Marrow Transplant,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3